Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 10 November 2025 to 14 November 2025

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 13 October 2025 to 17 October 2025

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 22 September 2025 to 26 September 2025

CHMP-CAT - D80-210 Overview to final EPAR - Rev 06.25 Revamp

List of metadata for the HMA-EMA Catalogues of real-world data sources and studies

User guide of the HMA-EMA Catalogues of real-world data sources and studies

Agenda - Workshop on the use of Bayesian statistics in clinical development

Perfusion solutions

Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop), leflunomide, Date of authorisation: 08/01/2010, Revision: 22, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0117/2024